Search Results 891-900 of 16927 for Amphotericin B
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
... B within the first 50 Exposure Days (ED). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
James B. Meiling, D.O.. Neuromuscular Disease Specialist; Physiatrist; Electrodiagnostic Physician. Rochester, MN ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Patients with R/R CLL must have been exposed to Bruton's tyrosine kinase (BTK) or B-Cell CLL/Lymphoma 2 (BCL2) inhibitor-based therapy in prior lines of ...
the near term (for at least 4 weeks). - Arm B: Participants must have received a necessary azole antifungal(s) that is a moderate or strong CYP3A4 inhibitor ...
Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells ...
Find a doctor whose last name begins with the letter B B · Find a doctor whose last name begins with the letter C C · active Find a doctor whose last name ...
Narrow your search · Find a doctor whose last name begins with the letter A A · Find a doctor whose last name begins with the letter B B · Find a doctor whose last ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.